Gautam G. Rao

ORCID: 0000-0002-3439-8147 · 3 papers in corpus
lab-animal 2022
Cancers ·doi:10.3390/cancers14030800

BACKGROUND: The development of chemoresistance to paclitaxel and carboplatin represents a major therapeutic challenge in ovarian cancer, a disease frequently characterized by malignant ascites and extrapelvic metastasis. Microtentacles (McT…

case-report 2002
Obstetrics & Gynecology ·doi:10.1016/s0029-7844(02)01936-1

BACKGROUND: BRCA1 mutation carriers are at high risk of developing epithelial ovarian cancer, but the transitional cell variant has not been previously reported in these patients. CASE: A nulligravid, perimenopausal woman underwent explora…

case-report 2002
·doi:10.1097/00006250-200205001-00029

BACKGROUND BRCA1 mutation carriers are at high risk of developing epithelial ovarian cancer, but the transitional cell variant has not been previously reported in these patients. CASE A nulligravid, perimenopausal woman underwent explorator…